Xometry’s (XMTR) “Market Outperform” Rating Reiterated at Citizens Jmp

Citizens Jmp reissued their market outperform rating on shares of Xometry (NASDAQ:XMTR) in a research report report published on Monday morning,Benzinga reports. Citizens Jmp currently has a $120.00 price objective on the stock.

A number of other equities analysts also recently issued reports on the company. UBS Group upped their price target on Xometry from $88.00 to $95.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 5th. Rosenblatt Securities began coverage on Xometry in a research note on Thursday, August 20th. They set a “buy” rating and a $110.00 target price on the stock. Wedbush began coverage on Xometry in a research report on Thursday, July 16th. They set an “outperform” rating and a $126.00 target price on the stock. The Goldman Sachs Group increased their price target on Xometry from $78.00 to $104.00 and gave the company a “neutral” rating in a research note on Wednesday, August 5th. Finally, Cantor Fitzgerald raised their price target on Xometry from $85.00 to $110.00 and gave the stock an “overweight” rating in a report on Wednesday, August 5th. Eight equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $113.18.

Xometry Stock Performance

XMTR stock opened at $105.01 on Monday. Xometry has a one year low of $35.86 and a one year high of $106.08. The firm has a market cap of $5.44 billion, a price-to-earnings ratio of -175.01 and a beta of 1.32. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.20 and a current ratio of 3.21. The firm has a 50-day simple moving average of $91.15 and a two-hundred day simple moving average of $76.51.

Xometry (NASDAQ:XMTR) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.01. The firm had revenue of $229.28 million for the quarter, compared to the consensus estimate of $215.22 million. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. The company’s quarterly revenue was up 41.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.09 EPS. On average, equities analysts forecast that Xometry will post -0.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Katharine Weymouth sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $95.23, for a total value of $476,150.00. Following the sale, the director owned 35,345 shares in the company, valued at $3,365,904.35. This represents a 12.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Emily Rollins sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $84.31, for a total value of $421,550.00. Following the completion of the sale, the director owned 15,136 shares in the company, valued at approximately $1,276,116.16. This represents a 24.83% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 57,053 shares of company stock valued at $5,244,213. Insiders own 9.10% of the company’s stock.

Hedge Funds Weigh In On Xometry

A number of institutional investors have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC grew its position in Xometry by 243.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 694,390 shares of the company’s stock worth $29,015,000 after purchasing an additional 492,285 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Xometry by 26.9% in the 2nd quarter. Wellington Management Group LLP now owns 1,322,581 shares of the company’s stock valued at $127,656,000 after buying an additional 280,491 shares during the period. Capital International Investors purchased a new stake in shares of Xometry in the fourth quarter worth about $11,949,000. BNP Paribas Financial Markets boosted its stake in shares of Xometry by 1,121.8% in the fourth quarter. BNP Paribas Financial Markets now owns 207,682 shares of the company’s stock worth $12,351,000 after buying an additional 190,684 shares during the last quarter. Finally, Sylebra Capital LLC grew its holdings in Xometry by 31.3% during the first quarter. Sylebra Capital LLC now owns 535,624 shares of the company’s stock worth $21,875,000 after acquiring an additional 127,637 shares during the period. 97.31% of the stock is owned by hedge funds and other institutional investors.

About Xometry

Xometry, Inc operates a digital marketplace that connects businesses with manufacturing suppliers. Its platform uses software and data-driven tools to help customers obtain quotes, place orders and manage production for custom parts and products.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet-metal fabrication, injection molding and urethane casting. Its services are used for prototyping and production across industries such as aerospace, automotive, industrial equipment, consumer products and healthcare.

Founded in 2013, Xometry has expanded its marketplace and related technology offerings through organic development and acquisitions, including the 2021 acquisition of Thomas, a digital industrial sourcing and marketing business.